Become A Wiser, More Profitable Investor

Endpoints Media Bias

---

Detailed Source Bias Analysis

This source predominantly covers the biopharmaceutical and biotechnology sectors, highlighting topics such as drug approvals, clinical trials, and corporate mergers.

The overall reporting style is generally neutral and factual, yet several critical nuances suggest deeper biases and omissions.

1. Pro-Industry Leanings

Notably, many articles present a positive outlook towards the pharmaceutical sector, often highlighting advancements without sufficient critical context about their societal implications.

For instance, the reporting on FDA approvals for various drugs typically emphasizes the successes of companies like Pfizer and Novartis, rather than addressing the high costs associated with these new treatments or their accessibility for patients Endpoints 

Close

Why did radiopharma biotech Actinium hold an investor event at Mar-a-Lago?

Article Bias: The article discusses Actinium Pharmaceuticals holding an investor event at Mar-a-Lago, highlighting the connection between the biotech sector and Donald Trump's resort, but lacks depth in analyzing the implications of this choice or the broader context, suggesting a slightly sensational slant without a strong ideological standpoint.

Endpoints Bias

Social Shares: 0

🔵 Liberal <—> Conservative 🔴:

🗽 Libertarian <—> Authoritarian 🚔:

🗞️ Objective <—> Subjective 👁️ :

🚨 Sensational:

📉 Bearish <—> Bullish 📈:

📝 Prescriptive:

🕊️ Dovish <—> Hawkish 🦁:

😨 Fearful:

📞 Begging the Question:

🗣️ Gossip:

💭 Opinion:

🗳 Political:

Oversimplification:

🏛️ Appeal to Authority:

🍼 Immature:

🔄 Circular Reasoning:

👀 Covering Responses:

😢 Victimization:

😤 Overconfident:

🗑️ Spam:

✊ Ideological:

🏴 Anti-establishment <—> Pro-establishment 📺:

🙁 Negative <—> Positive 🙂:

📏📏 Double Standard:

❌ Uncredible <—> Credible ✅:

🧠 Rational <—> Irrational 🤪:

🤑 Advertising:

🤖 Written by AI:

💔 Low Integrity <—> High Integrity ❤️:

AI Bias: I'm trained on diverse data, may reflect mainstream perspectives.

Article Text:
Please login or sign up to view

Close

, Endpoints 

Close

J&J touts new survival data for lung cancer combo

Article Bias: The article presents Johnson & Johnson's positive lung cancer treatment data, favoring their product in comparison to AstraZeneca without addressing potential drawbacks or skepticism, showing a bias towards corporate interests in the pharmaceutical sector.

Endpoints Bias

Social Shares: 14

🗞️ Objective <—> Subjective 👁️ :

🚨 Sensational:

📝 Prescriptive:

💭 Opinion:

🏴 Anti-establishment <—> Pro-establishment 📺:

❌ Uncredible <—> Credible ✅:

🤑 Advertising:

🦊 Anti-Corporate <—> Pro-Corporate 👔:

🐍 Manipulative:

🤖 Written by AI:

💔 Low Integrity <—> High Integrity ❤️:

AI Bias: I focus on neutrality but may reflect data-driven perspectives.

Article Text:
Please login or sign up to view

Close

.

2. Omission of Critical Perspectives

While the articles cover substantial developments, they occasionally lack in-depth analysis regarding issues of drug pricing, accessibility, and broader public health implications.

A case in point is the coverage of controversial topics revolving around opioid prescriptions, where the narratives lean towards corporate strategies, often neglecting the socio-economic impact of such decisions and public critique Endpoints 

Close

UK's drugmaker rebate plan draws scrutiny from industry

Article Bias: The article reports on the UK government's plan to increase financial contributions from drugmakers to the NHS, eliciting industry backlash, but lacks in-depth analysis of the implications or diverse perspectives, suggesting a possible industry bias.

Endpoints Bias

Social Shares: 0

🔵 Liberal <—> Conservative 🔴:

🗽 Libertarian <—> Authoritarian 🚔:

🗞️ Objective <—> Subjective 👁️ :

🚨 Sensational:

📉 Bearish <—> Bullish 📈:

📝 Prescriptive:

🕊️ Dovish <—> Hawkish 🦁:

😨 Fearful:

📞 Begging the Question:

🗣️ Gossip:

💭 Opinion:

🗳 Political:

Oversimplification:

🏛️ Appeal to Authority:

🍼 Immature:

🔄 Circular Reasoning:

👀 Covering Responses:

😢 Victimization:

😤 Overconfident:

🗑️ Spam:

✊ Ideological:

🏴 Anti-establishment <—> Pro-establishment 📺:

🙁 Negative <—> Positive 🙂:

📏📏 Double Standard:

❌ Uncredible <—> Credible ✅:

🧠 Rational <—> Irrational 🤪:

🤑 Advertising:

🦊 Anti-Corporate <—> Pro-Corporate 👔:

🤖 Written by AI:

💔 Low Integrity <—> High Integrity ❤️:

AI Bias: Neutral but cautious approach to analyzing biases.

Article Text:
Please login or sign up to view

Close

, Endpoints 

Close

BioNTech details promising mid-stage data for its PD-L1xVEGF in aggressive lung cancer

Article Bias: The article presents BioNTech's encouraging data regarding a new lung cancer treatment in a straightforward manner, focusing on the scientific developments without evident bias towards any particular viewpoint while including some extraneous content related to subscriptions and e-mail services.

Endpoints Bias

Social Shares: 0

🗞️ Objective <—> Subjective 👁️ :

🚨 Sensational:

📝 Prescriptive:

💭 Opinion:

Oversimplification:

🗑️ Spam:

🏴 Anti-establishment <—> Pro-establishment 📺:

🙁 Negative <—> Positive 🙂:

❌ Uncredible <—> Credible ✅:

🧠 Rational <—> Irrational 🤪:

🤑 Advertising:

🔬 Scientific <—> Superstitious 🔮:

🐍 Manipulative:

💔 Low Integrity <—> High Integrity ❤️:

AI Bias: Limited to pre-October 2023 data, favoring accuracy.

Article Text:
Please login or sign up to view

Close

.

3. Political Dimensions

The source occasionally engages with political issues, particularly in relation to prominent figures like Robert F. Kennedy Jr. and the Trump administration.

However, the tone tends to remain neutral, lacking a thorough exploration of these interactions’ implications within the context of health policy Endpoints 

Close

Kennedy's anti-vaccine actions shouldn't surprise anyone

Article Bias: The article expresses skepticism towards Robert F. Kennedy Jr.'s portrayal as a moderate, particularly focusing on his anti-vaccine stance, suggesting a critical perspective on his views.

Endpoints Bias

Social Shares: 0

🔵 Liberal <—> Conservative 🔴:

🗽 Libertarian <—> Authoritarian 🚔:

🗞️ Objective <—> Subjective 👁️ :

🚨 Sensational:

📉 Bearish <—> Bullish 📈:

📝 Prescriptive:

🕊️ Dovish <—> Hawkish 🦁:

😨 Fearful:

📞 Begging the Question:

🗣️ Gossip:

💭 Opinion:

🗳 Political:

Oversimplification:

🏛️ Appeal to Authority:

🍼 Immature:

🔄 Circular Reasoning:

👀 Covering Responses:

😢 Victimization:

😤 Overconfident:

🗑️ Spam:

✊ Ideological:

🏴 Anti-establishment <—> Pro-establishment 📺:

🙁 Negative <—> Positive 🙂:

📏📏 Double Standard:

❌ Uncredible <—> Credible ✅:

🧠 Rational <—> Irrational 🤪:

🤑 Advertising:

🔬 Scientific <—> Superstitious 🔮:

🤖 Written by AI:

💔 Low Integrity <—> High Integrity ❤️:

AI Bias: Limited by data, focusing on neutrality and objectivity.

Article Text:
Please login or sign up to view

Close

, Endpoints 

Close

FDA's Peter Marks resigns, in disagreement with Kennedy

Article Bias: The article discusses the resignation of Peter Marks from the FDA amid conflicts with the Trump administration regarding misinformation, suggesting a potential bias against the administration but lacking sufficient context for a definitive stance.

Endpoints Bias

Social Shares: 101

AI Bias: Inherent limitations in nuanced understanding of context.

Article Text:
Please login or sign up to view

Close

.

4. Bias of Omission

The lack of coverage regarding the ethical dilemmas around pharmaceutical marketing practices and their effects further highlights a potential pro-industry bias, which may inadvertently downplay critical discussions on drug safety and efficacy, particularly illustrated by the piece discussing drug failures or adverse drug events Endpoints 

Close

Before Alumis went public via IPO, it tried doing a reverse merger with Acelyrin

Article Bias: The article primarily discusses the financial merger activities between Alumis and Acelyrin, presenting information in a straightforward manner with a focus on fact-based reporting.

Endpoints Bias

Social Shares: 0

🔵 Liberal <—> Conservative 🔴:

🗽 Libertarian <—> Authoritarian 🚔:

🗞️ Objective <—> Subjective 👁️ :

🚨 Sensational:

📉 Bearish <—> Bullish 📈:

📝 Prescriptive:

🕊️ Dovish <—> Hawkish 🦁:

😨 Fearful:

📞 Begging the Question:

🗣️ Gossip:

💭 Opinion:

🗳 Political:

Oversimplification:

🏛️ Appeal to Authority:

🍼 Immature:

🔄 Circular Reasoning:

👀 Covering Responses:

😢 Victimization:

😤 Overconfident:

🗑️ Spam:

✊ Ideological:

🏴 Anti-establishment <—> Pro-establishment 📺:

🙁 Negative <—> Positive 🙂:

📏📏 Double Standard:

❌ Uncredible <—> Credible ✅:

🧠 Rational <—> Irrational 🤪:

🤑 Advertising:

🤖 Written by AI:

💔 Low Integrity <—> High Integrity ❤️:

AI Bias: Limited to the data I've been trained on.

Article Text:
Please login or sign up to view

Close

, Endpoints 

Close

European regulator rejects Lilly's Alzheimer's drug over side effects

Article Bias: The article reports on the rejection of Eli Lilly’s Alzheimer's drug Kisunla by the European Medicines Agency, emphasizing the serious side effects and patient deaths that contributed to this decision; it presents factual information with minimal emotional language or speculation, indicating a primarily objective stance.

Endpoints Bias

Social Shares: 35

🔵 Liberal <—> Conservative 🔴:

🗽 Libertarian <—> Authoritarian 🚔:

🗞️ Objective <—> Subjective 👁️ :

🚨 Sensational:

📉 Bearish <—> Bullish 📈:

📝 Prescriptive:

🕊️ Dovish <—> Hawkish 🦁:

😨 Fearful:

📞 Begging the Question:

🗣️ Gossip:

💭 Opinion:

🗳 Political:

Oversimplification:

🏛️ Appeal to Authority:

🍼 Immature:

🔄 Circular Reasoning:

👀 Covering Responses:

😢 Victimization:

😤 Overconfident:

🗑️ Spam:

✊ Ideological:

🏴 Anti-establishment <—> Pro-establishment 📺:

🙁 Negative <—> Positive 🙂:

📏📏 Double Standard:

❌ Uncredible <—> Credible ✅:

🧠 Rational <—> Irrational 🤪:

🤑 Advertising:

🔬 Scientific <—> Superstitious 🔮:

🤖 Written by AI:

💔 Low Integrity <—> High Integrity ❤️:

AI Bias: Trained on diverse data; may lack specificity on niche subjects.

Article Text:
Please login or sign up to view

Close

.

5. Style and AI Generation Concerns

Despite the straightforward and neutral style observed, certain articles exhibit a formulaic nature that could suggest aspects of AI generation, although there is no overtly mechanical writing evident.

This points towards an intent to convey industry-specific news for an audience interested in these developments Endpoints 

Close

J&J touts new survival data for lung cancer combo

Article Bias: The article presents Johnson & Johnson's positive lung cancer treatment data, favoring their product in comparison to AstraZeneca without addressing potential drawbacks or skepticism, showing a bias towards corporate interests in the pharmaceutical sector.

Endpoints Bias

Social Shares: 14

🗞️ Objective <—> Subjective 👁️ :

🚨 Sensational:

📝 Prescriptive:

💭 Opinion:

🏴 Anti-establishment <—> Pro-establishment 📺:

❌ Uncredible <—> Credible ✅:

🤑 Advertising:

🦊 Anti-Corporate <—> Pro-Corporate 👔:

🐍 Manipulative:

🤖 Written by AI:

💔 Low Integrity <—> High Integrity ❤️:

AI Bias: I focus on neutrality but may reflect data-driven perspectives.

Article Text:
Please login or sign up to view

Close

, Endpoints 

Close

FDA approves Sanofi's RNAi drug for hemophilia A and B

Article Bias: The article succinctly reports the FDA's approval of a new RNAi treatment from Sanofi for hemophilia, without expressing a clear ideological stance or emotional tone, indicating a neutral and factual approach to conveying the information.

Endpoints Bias

Social Shares: 0

🔵 Liberal <—> Conservative 🔴:

🗽 Libertarian <—> Authoritarian 🚔:

🗞️ Objective <—> Subjective 👁️ :

🚨 Sensational:

📉 Bearish <—> Bullish 📈:

📝 Prescriptive:

🕊️ Dovish <—> Hawkish 🦁:

😨 Fearful:

📞 Begging the Question:

🗣️ Gossip:

💭 Opinion:

🗳 Political:

Oversimplification:

🏛️ Appeal to Authority:

🍼 Immature:

🔄 Circular Reasoning:

👀 Covering Responses:

😢 Victimization:

😤 Overconfident:

🗑️ Spam:

✊ Ideological:

🏴 Anti-establishment <—> Pro-establishment 📺:

🙁 Negative <—> Positive 🙂:

📏📏 Double Standard:

❌ Uncredible <—> Credible ✅:

🧠 Rational <—> Irrational 🤪:

🤑 Advertising:

🦊 Anti-Corporate <—> Pro-Corporate 👔:

🔬 Scientific <—> Superstitious 🔮:

🤖 Written by AI:

💔 Low Integrity <—> High Integrity ❤️:

AI Bias: I aim for neutrality but may reflect training data limitations.

Article Text:
Please login or sign up to view

Close

.

Helium Bias: I recognize my training data may prioritize mainstream narratives, impacting my analysis by possibly overlooking niche perspectives or emerging debates.

(?)  March 29, 2025

Current Endpoints Bias

Understanding Media Bias      View All Sources     

---

Customize Your AI News Feed. No Censorship. No Ads.

---

How To Interpret?

---

Endpoints Recent Articles

Sort By:      Conservative Liberal Date Bullish Bearish Sensational Objectivity Relevance Popularity Interesting Positive